Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 04, 2015 11:37 AM ET

Biotechnology

Company Overview of Synthetic Genomics, Inc.

Company Overview

Synthetic Genomics, Inc., a synthetic biology company, develops and commercializes genomic-driven solutions and products for various industries worldwide. The company focuses on various commercialization programs, including developing synthetic DNA products, tools, and instruments for organizations with demands for large and/or complex DNA constructs; algae based food and nutritional products, and biofuels; and synthetically-derived vaccines and anti-microbials. It also develops clean water technologies using microbial fuel cells; and sustainable agricultural products. Synthetic Genomics, Inc. was formerly known as Synthetic Genomic Solutions, Inc. The company was founded in 2005 and is base...

11149 North Torrey Pines Road

La Jolla, CA 92037

United States

Founded in 2005

Phone:

858-754-2900

Fax:

858-754-2988

Key Executives for Synthetic Genomics, Inc.

Chief Executive Officer and Director
Age: 51
Co-Founder, Executive Chairman and Co-Chief Scientific Officer
Co-Founder, Co-Chief Scientific Officer and Director
Co-Founder, Executive Vice President, General Counsel and Director
Co-Founder, Chief Business Officer and Director
Age: 55
Compensation as of Fiscal Year 2015.

Synthetic Genomics, Inc. Key Developments

Synthetic Genomics, Inc. and Gen9 Sign Licensing Agreement for Synthetic Biology Technology Patents

Synthetic Genomics, Inc. and Gen9 Inc. announced a strategic licensing agreement to leverage their respective strengths in synthetic biology technology development and commercialization. The agreement provides Gen9 Inc. with a non-exclusive worldwide license to SGI's Febit intellectual property estate. The financial details of the agreement were not disclosed.

Synthetic Genomics, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015

Synthetic Genomics, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 . Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.

Synthetic Genomics, Inc. Appoints Oliver Fetzer as Chief Executive Officer and Director

Synthetic Genomics, Inc. announced the appointment of Oliver Fetzer as a Chief Executive Officer (CEO). In his role as CEO, Fetzer will also be a member of SGI's Board of Directors. Dr. Fetzer will lead all aspects of SGI, including management of SGI's three business units--SGI-DNA, Synthetic Genomics Vaccines, Inc. (SGVI), and Genovia Bio. Dr. Fetzer comes to SGI from Cerulean Pharma Inc., where he was President and CEO for five years.

Similar Private Companies By Industry

Company Name Region
g-TAC Bio Medical United States
Ichor Medical Systems, Inc. United States
SKS Ocular, LLC United States
Agilvax, Inc. United States
Syngenta Biotechnology, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Synthetic Genomics, Inc., please visit www.syntheticgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.